Skip to main content
. 2019 Jul-Aug;94(4):458–460. doi: 10.1590/abd1806-4841.20198349

Table 2.

Immunohistochemical results

  VE1-positive KIT-positive
TM subgroup 17/32 (53.1%) 23/35 (65.7%)
MIS subgroup 03/08 (37.5%) 08/09 (88.8%)
Total 20/40 (50%) 31/44 (70.4%)